An Observational Study of Xeloda (Capecitabine) in Participants With Metastatic or Advanced Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: Capecitabine
Sponsor: Hoffmann-La Roche